Microbiologic considerations in the treatment of serious pelvic infections in women

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Pelvic inflammatory disease (PID) treatment is often empirical.
• Knowledge of female genital tract microbiology is crucial for selecting appropriate antibiotic therapy.
• Common pathogens in PID include Chlamydia trachomatis and Neisseria gonorrhoeae.

Purpose of the Study:

• To review the microbiology of the female genital tract relevant to pelvic inflammatory disease (PID).
• To discuss antibiotic agents effective against common PID pathogens.
• To compare the activity of broad-spectrum cephalosporins against specific bacterial isolates.

Main Methods:

• Literature review of studies on female genital tract microbiology and antibiotic efficacy.
• Analysis of antibiotic activity against Chlamydia trachomatis, Neisseria gonorrhoeae, and other relevant bacteria.
• Comparison of broad-spectrum cephalosporins, including ceftizoxime, cefoxitin, and cefotetan.

Main Results:

• Tetracycline and erythromycins are effective against Chlamydia trachomatis.
• Spectinomycin and broad-spectrum cephalosporins are recommended for penicillinase-producing Neisseria gonorrhoeae.
• Ceftizoxime demonstrates superior activity against Bacteroides fragilis group and enteric bacilli compared to cefoxitin and cefotetan.

Conclusions:

• Informed antibiotic selection for PID requires understanding causative pathogens and their susceptibility.
• Ceftizoxime offers a favorable spectrum of activity against key bacterial flora implicated in PID.
• Tailoring antibiotic therapy based on microbiological data improves PID management.